We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
19 hedge funds and large institutions have $883K invested in CASI Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 19 → 19 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.79% less ownership
Funds ownership: 3.38% → 2.59% (-0.79%)
22% less capital invested
Capital invested by funds: $1.12M → $883K (-$242K)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$116K |
| 2 |
WSCM
Wellington Shields Capital Management
New York
|
-$59.2K |
| 3 |
WSC
Wellington Shields & Co
New York
|
-$28.5K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$25.8K |
| 5 |
Jane Street
New York
|
-$14.3K |
